Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CleveX Inc.

This article was originally published in Start Up

Executive Summary

Patients undergoing a biopsy of a skin lesion will soon have the option to be treated in-office with a novel device that is quicker and more cosmetically acceptable than traditional methods. So says CleveX, which is developing the ExiClip, an inexpensive, compact, single-use product for biopsy, skin lesion removal and wound closure. The ExiClip procedure can be performed in less than five minutes. Tissue is pulled through the lesion aperture, then finger holds on the device are squeezed together that cause a proprietary skin clip to secure the skin tissue. Immediately afterwards, a blade moves across the aperture and excises the tissue. Hence, biopsy and closure occurs almost simultaneously.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037541

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel